SMTL ID : 8g8x.1

X-ray co-crystal structure of compound 27 in with complex JAK2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.97 Å

Oligo State

homo-dimer

Ligands

2 x YT8: 3-cyclopropyl-1-{5-methyl-2-[(3-methyl-1,2-thiazol-5-yl)amino]pyrimidin-4-yl}azetidin-3-ol(Non-covalent)

YT8.1: 13 residues within 4Å: Chain A: L.41, V.49, A.66, M.115, E.116, Y.117, L.118, G.121, R.166, N.167, L.169, G.179, D.180 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.41, A:A.66, A:Y.117, A:L.169, A:L.169, A:D.180 Hydrogen bonds: A:L.118, A:L.118 Water bridges: A:S.122 YT8.2: 13 residues within 4Å: Chain B: L.41, V.49, A.66, M.115, E.116, Y.117, L.118, G.121, R.166, N.167, L.169, G.179, D.180 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:A.66, B:Y.117, B:L.169, B:L.169, B:D.180 Hydrogen bonds: B:L.118, B:L.118 Water bridges: B:S.122

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gordhan, H.M. et al., Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous Solubility. J.Med.Chem. (2023)

Release Date

2023-06-21

Peptides

Tyrosine-protein kinase JAK2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence